312 related articles for article (PubMed ID: 29314143)
1. Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.
Duintjer Tebbens RJ; Pallansch MA; Cochi SL; Ehrhardt DT; Farag NH; Hadler SC; Hampton LM; Martinez M; Wassilak SGF; Thompson KM
Risk Anal; 2018 Aug; 38(8):1701-1717. PubMed ID: 29314143
[TBL] [Abstract][Full Text] [Related]
2. Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and Afghanistan.
Kalkowska DA; Thompson KM
Risk Anal; 2021 Feb; 41(2):266-272. PubMed ID: 32144841
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan.
Duintjer Tebbens RJ; Thompson KM
Risk Anal; 2019 Feb; 39(2):389-401. PubMed ID: 30239026
[TBL] [Abstract][Full Text] [Related]
4. Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.
Duintjer Tebbens RJ; Thompson KM
J Infect Dis; 2014 Nov; 210 Suppl 1():S485-97. PubMed ID: 25316871
[TBL] [Abstract][Full Text] [Related]
5. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
[TBL] [Abstract][Full Text] [Related]
6. Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria.
Duintjer Tebbens RJ; Pallansch MA; Wassilak SG; Cochi SL; Thompson KM
PLoS One; 2015; 10(6):e0130123. PubMed ID: 26068928
[TBL] [Abstract][Full Text] [Related]
7. The effect of mass immunisation campaigns and new oral poliovirus vaccines on the incidence of poliomyelitis in Pakistan and Afghanistan, 2001-11: a retrospective analysis.
O'Reilly KM; Durry E; ul Islam O; Quddus A; Abid N; Mir TP; Tangermann RH; Aylward RB; Grassly NC
Lancet; 2012 Aug; 380(9840):491-8. PubMed ID: 22766207
[TBL] [Abstract][Full Text] [Related]
8. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
[TBL] [Abstract][Full Text] [Related]
9. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
[TBL] [Abstract][Full Text] [Related]
10. Introduction of Inactivated Poliovirus Vaccine and Switch from Trivalent to Bivalent Oral Poliovirus Vaccine - Worldwide, 2013-2016.
Immunization Systems Management Group of the Global Polio Eradication Initiative
MMWR Morb Mortal Wkly Rep; 2015 Jul; 64(25):699-702. PubMed ID: 26135591
[TBL] [Abstract][Full Text] [Related]
11. Managing population immunity to reduce or eliminate the risks of circulation following the importation of polioviruses.
Thompson KM; Kalkowska DA; Duintjer Tebbens RJ
Vaccine; 2015 Mar; 33(13):1568-77. PubMed ID: 25701673
[TBL] [Abstract][Full Text] [Related]
12. Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes.
Thompson KM; Duintjer Tebbens RJ
BMC Infect Dis; 2015 Sep; 15():374. PubMed ID: 26381878
[TBL] [Abstract][Full Text] [Related]
13. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
14. Progress toward poliomyelitis eradication--Afghanistan and Pakistan, 2008.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Mar; 58(8):198-201. PubMed ID: 19265781
[TBL] [Abstract][Full Text] [Related]
15. An economic analysis of poliovirus risk management policy options for 2013-2052.
Duintjer Tebbens RJ; Pallansch MA; Cochi SL; Wassilak SG; Thompson KM
BMC Infect Dis; 2015 Sep; 15():389. PubMed ID: 26404632
[TBL] [Abstract][Full Text] [Related]
16. Progress toward poliomyelitis eradication - Afghanistan and Pakistan, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):268-72. PubMed ID: 20224544
[TBL] [Abstract][Full Text] [Related]
17. Updated Characterization of Poliovirus Transmission in Pakistan and Afghanistan and the Impacts of Different Outbreak Response Vaccine Options.
Kalkowska DA; Pallansch MA; Cochi SL; Thompson KM
J Infect Dis; 2021 Nov; 224(9):1529-1538. PubMed ID: 33885734
[TBL] [Abstract][Full Text] [Related]
18. Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
Sarnquist C; Holubar M; García-García L; Ferreyra-Reyes L; Delgado-Sánchez G; Cruz-Hervert LP; Montero-Campos R; Altamirano J; Purington N; Boyle S; Modlin J; Ferreira-Guerrero E; Canizales-Quintero S; Díaz Ortega JL; Desai M; Maldonado YA
Clin Infect Dis; 2018 Oct; 67(suppl_1):S115-S120. PubMed ID: 30376084
[TBL] [Abstract][Full Text] [Related]
19. Global Polio Eradication,The Journey So Far.
Thacker N; Yewale VN; Pathak A
Indian Pediatr; 2016 Aug; 53 Suppl 1():S61-S64. PubMed ID: 27771642
[TBL] [Abstract][Full Text] [Related]
20. Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria.
Kalkowska DA; Duintjer Tebbens RJ; Thompson KM
J Infect Dis; 2014 Nov; 210 Suppl 1():S412-23. PubMed ID: 25316863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
